Cerulean Pharma Inc. To Host First-Quarter 2015 Conference Call On May 6

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Cerulean Pharma Inc. (Nasdaq: CERU), a leader in Dynamic Tumor Targeting™, today announced it will provide an update on corporate activities for the first-quarter 2015 on May 6.

Christopher D. T. Guiffre, JD, MBA, President and Chief Executive Officer, and Paul Friedman, M.D., Executive Chairman will conduct a conference call at 4:30 p.m. ET that day to provide a business update and review the Company's first-quarter financial results. The call can be accessed by dialing (844) 831-3031 or (443) 637-1284 prior to the start of the call and referencing conference ID 33646103.

Help employers find you! Check out all the jobs and post your resume.
MORE ON THIS TOPIC